1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010. doi: 10.1016/j.ejca.2009.12.014 .
2. Gadgeel SM. The optimal chemotherapy for stage III non-small cell lung cancer patients. Curr Oncol Rep. 2011. doi: 10.1007/s11912-011-0170-3 .
3. Choudhury A, Palma M, Mellstedt H. The future of cancer vaccines for non-small-cell lung cancer: ongoing trials. Clin Lung Cancer. 2008. doi: 10.3816/CLC.2008.s.006 .
4. Kelly RJ, Gulley JL, Giaccone G. Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality. Clin Lung Cancer. 2010. doi: 10.3816/CLC.2010.n.029 .
5. Li H, Wang C, Yu J, Cao S, Wei F, Zhang W, et al. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy. 2009. doi: 10.3109/14653240903121252 .